Journal of Community Pharmacy Practice

Evaluating the effectiveness of public medicine use education campaigns on knowledge and practice behaviors: a statistical analysis

Santibuana Abd Rahman — Sat, 04 Apr 2026 00:00:00 +0000

Article History: Received: 05 August 2025 Revised: 13 October 2025 Accepted: 20 October 2025 Published: 04 January 2026 Background: Public education campaigns represent a key strategy in promoting health literacy and responsible medicine use. However, evidence on their effectiveness in improving both knowledge and self-reported health practices among general populations remains limited, particularly in community-level settings.

Objective: To evaluate the effectiveness of a public education campaign on medicine use by measuring changes in Knowledge-Practice Scores among participants before and after the intervention.

Methods: A comparative pre- and post-campaign study design was employed. Participants were assessed at two time points corresponding to pre-campaign and post-campaign groups. One-Way ANOVA and descriptive statistics were applied to evaluate between-group differences in Knowledge-Practice Scores. Demographic patterns across participant subgroups were also examined.

Results: Post-campaign participants demonstrated a statistically significant increase in Knowledge-Practice Scores compared to the pre-campaign group (p < .001), indicating measurable improvement in both public knowledge and self-reported responsible practices related to medicine use. Descriptive analysis further revealed notable demographic variation in participant data, suggesting differential engagement or baseline characteristics across subpopulations.

Conclusions: A targeted public education campaign on medicine use produced significant gains in knowledge and responsible health practices among the general population. Health communication strategies delivered at the community level can meaningfully advance health literacy outcomes. Findings support the scaling up of such initiatives and highlight the potential value of tailoring future campaigns to specific demographic subgroups to maximize impact.

Role of community pharmacists in managing hypertension and diabetes: a patient-centered approach

Vaishnavi Kolli — Fri, 23 Jan 2026 00:00:00 +0000

Background: Type 2 diabetes mellitus (T2DM) and hypertension are leading causes of cardiovascular morbidity and mortality worldwide. Community pharmacists offer an accessible, localized solution for bridging chronic disease treatment gaps. Despite this potential, pharmacist-led patient-centered care for these comorbidities remains under-researched in low-and middle-income settings.

Purpose: This study critically assessed clinical, behavioral, and financial outcomes of community pharmacist-led interventions in patients with hypertension and/or T2DM using a patient-centered care model.

Methods: A mixed-methods cross-sectional study was conducted across 12 community pharmacies over six months. In all, 450 adult patients (>18 years) diagnosed with hypertension, T2DM, or both were recruited. Structured interventions included medication therapy management (MTM), adherence counseling, disease-state education, and self-monitoring training. Systolic and diastolic blood pressure, HbA1c, and fasting blood glucose were measured at baseline and three-month follow-up. Patient satisfaction was assessed using a 10-item Likert scale.

Findings: Significant improvements were observed post-intervention. Mean systolic blood pressure declined from 158.4 ± 14.2 to 138.7 ± 11.6 mmHg (p < 0.001), and HbA1c decreased from 8.6 ± 1.1% to 7.4 ± 0.9% (p < 0.001). Medication adherence and patient satisfaction scores improved by 36.2 and 31.0 points, respectively. Key barriers included poor reimbursement frameworks, absence of integrated health records, and ineffective inter-professional collaboration.

Conclusion: Community-based pharmacist interventions significantly improved clinical outcomes and patient satisfaction in patients with hypertension and diabetes. Integrating pharmacist-led care into patient-centered models through policy reform and digital health holds strong potential for global chronic disease management.

Impact of community pharmacist interventions on medication adherence in chronic disease patients

Jasvitha Mandava — Sat, 28 Feb 2026 00:00:00 +0000

Background: Medicine non-adherence among chronic disease patients is a significant health issue worldwide. Community pharmacists are the only people that are in a strategic position to provide organized interventions that enhance adherence outcomes.

Objective: This is a systematic review and meta-analysis study that aims to determine the effectiveness of community pharmacist-led interventions in enhancing medication adherence in patients with chronic non-communicable conditions.

Methods: The systematic search of studies published between January 2010 and December 2024 in PubMed, Scopus, Web of Science, and CINAHL was performed. Randomized controlled trials and quasi-experimental studies of pharmacist interventions to enhance adherence were considered. The Cochrane Risk of Bias 2.0 tool and the ROBINS-I instrument were used to evaluate the risk of bias.

Result: There were 59 studies that comprised 28,741 patients. Meta-analysis revealed pharmacist interventions significantly improved adherence (OR=2.47, 95% CI: 2.01–3.04, p<0.001, I²=43.6%). Medication therapy management (MTM) produced the greatest gains in adherence (OR=2.89) followed by telephonic follow up (OR=2.41) and patient counselling (OR=2.18). The greatest benefit was observed in hypertension and diabetes subgroups.

Conclusion: Community pharmacist interventions have significant impacts on improving medication adherence among patients with chronic diseases. Healthcare policy makers highly recommend integration of pharmacists into multidisciplinary care teams.